Adaptive Biotechnologies Corp
ADPT
$25.57-3.47%
End of day · as of Oct 12, 2026, 10:30 PM ET
Mkt cap
$2.69B
EV/Sales
9.92
P/E ratio
N/A
FY2025 Revenue
$276.98M
EPS (TTM)
$-0.40
Gross Margin (FY2025)
74.24%
Profit Margin (FY2025)
-21.48%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
Latest reported ADPT revenue for 2025-12-31 was $277.0M. Net income was -$59.5M. Revenue was up 54.8% from 2024-12-31 to 2025-12-31. ADPT currently screens at market cap $2.69B.
Use this ADPT research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ADPT income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company in the Healthcare sector.
Latest cached Adaptive Biotechnologies Corp (ADPT) revenue for Dec 31, 2025 was $277.0M. Net income was -$59.5M. Statements: https://lician.com/financials/adpt
Adaptive Biotechnologies Corp (ADPT) market capitalization is $2.69B on the latest cached snapshot.
Adaptive Biotechnologies Corp (ADPT) cached previous close $26.49; day range $24.53 – $26.36; volume 3,117,014. Session quote: https://lician.com/quote/adpt
Adaptive Biotechnologies Corp (ADPT) latest cached earnings event is "ADPT earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ADPT filing is 8-K · Jan 12, 2026. Filings: https://lician.com/sec/adpt